FdaApplication

ANDA 215016

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTORRENT PHARMA INC
application_typeANDA
approval_date2021-12-27

Products (1)

ProductActive ingredientStrengthDosage form
SIROLIMUSSIROLIMUS1MG/MLSOLUTION;ORAL

1 product